The University of Cambridge is a collegiate research university in Cambridge, United Kingdom. Founded in 1209 and granted a royal charter by King Henry III in 1231, Cambridge is the second-oldest university in the English-speaking world and the world’s fourth-oldest surviving university
Furthermore, the overarching aim of this PhD is to develop NMR diffusion and T1/T2 relaxometry techniques for low-field, benchtop NMR systems ultimately providing a non-invasive NMR tool that can be used in/at the biopharmaceutical production line to monitor critical cell growth and productivity parameters.
In addition, this project will use magnetic resonance imaging (MRI) velocimetry to study the flow and shear fields inside the retention filters of a perfusion bioreactor in order to gain a more quantitative understanding of mass transfer during such processes.
Low-field NMR/MRI in Biopharmaceutical Development
Worth of Award
- The PhD in Application of Low-Field NMR/MRI in Biopharmaceutical Development 2021 provides fees and maintenance for 4 years.
- Be a UK or EU national (Non-UK/non-EU nationals are not eligible and should not apply.)
- Additionally, have a first-class or high 2.i, or equivalent degree in chemistry, biochemistry, or a related discipline.
- Likewise, be able to meet the minimum entry criteria: Link
How to apply:
The studentship may start in January 2021. Additionally, to apply for this studentship, please submit a formal application for admission to study Chemical Engineering
- There is no separate application. Applicants will be considered after getting Graduate Admission
- However, shortlisted candidates will be invited to submit a supporting statement to compete for this award.
For more information, visit the Official Webpage
Application deadline: 31st August 2020.